secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001213900-26-039363
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics closes $2.0M registered direct offering of 2.86M shares at $0.70 plus warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$2.0M from sale of 2,857,144 shares at $0.70 each; used for working capital.
- Warrants issued: 2,857,144 shares at $0.85, exercisable 6 months from issuance, 5.5-year term.
- Placement agent: H.C. Wainwright & Co. — 7% cash fee, 5% warrant coverage at $0.875 per share.
- Company suspended its existing ATM equity program pending new prospectus supplement.
- Offering closed April 2, 2026 as announced in a separate press release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390026039363/0001213900-26-039363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390026039363/ea0284778-8k_hoth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-039363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer